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Summary
Objective: To describe the implementation of medical
revalidation in healthcare organisations in the United
Kingdom and to examine reported changes and impacts
on the quality of care.
Design: A cross-sectional online survey gathering both
quantitative and qualitative data about structures and pro-
cesses for medical revalidation and wider quality manage-
ment in the organisations which employ or contract with
doctors (termed ‘designated bodies’) from the senior
doctor in each organisation with statutory responsibility
for medical revalidation (termed the ‘Responsible Officer’).
Setting: United Kingdom
Participants: Responsible Officers in designated bodies in
the United Kingdom. Five hundred and ninety-five survey
invitations were sent and 374 completed surveys were
returned (63%).
Main outcome measures: The role of Responsible
Officers, the development of organisational mechanisms
for quality assurance or improvement, decision-making on
revalidation recommendations, impact of revalidation and
mechanisms for quality assurance or improvement on clin-
ical practice and suggested improvements to revalidation
arrangements.
Results: Responsible Officers report that revalidation has
had some impacts on the way medical performance is
assured and improved, particularly strengthening appraisal
and oversight of quality within organisations and having
some impact on clinical practice. They suggest changes to
make revalidation less ‘one size fits all’ and more respon-
sive to individual, organisational and professional contexts.
Conclusions: Revalidation appears primarily to have
improved systems for quality improvement and the man-
agement of poor performance to date. There is more to be
done to ensure it produces wider benefits, particularly in
relation to doctors who already perform well.
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Background
The introduction of medical revalidation in 2012,1
after over a decade of protracted policy development
and debate,2 has been described as the most import-
ant change to the way that medical professionals are
regulated in the United Kingdom for 100 years.3 Put
simply, it requires all licenced doctors ‘to demon-
strate on a regular basis that they are up to date
and fit to practise in their chosen field and able to
provide a good level of care’.4
Medical revalidation was intended to address long-
standing concerns about the accountability of doctors
and the quality of medical care,5,6 which became the
subject of close public and political scrutiny following
a number of inquiries into major failures.7 The pur-
pose of revalidation has not always been clear8 but
two main aims have featured – that it should deal
more effectively with poor or unacceptable practice,
and that it should help doctors to improve their prac-
tice. There has been extensive professional scepticism9
about whether it can achieve these aims, and concern
about its costs which were estimated by the
Department of Health as £97 million a year.10
For both doctors and organisations, medical reval-
idation involves important changes to the way that
medical performance is managed and assured.
It requires healthcare organisations which employ
doctors to introduce some new processes for dealing
with issues of medical quality and performance and to
consider how these relate to existing processes.
Revalidation requires every licensed doctor to be con-
nected to one designated body, which is usually their
main employer. They must collect, report and reflect
on information about various aspects of their per-
formance through an annual appraisal. Healthcare
organisations must, through a nominated
Responsible Officer, make informed decisions every
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five years about whether to recommend to the General
Medical Council that a doctor be revalidated, and
thus allowed to continue to practise. This presumes
the existence of a number of organisational systems
for managing medical performance, such as clinical
audit/quality improvement, continuing professional
development, incident reporting and investigation,
and complaints management. One of the potential
impacts of the introduction of revalidation is that it
would lead to changes in these systems for managing
medical performance and the way they are used.
Both the Department of Health’ Policy Research
Programme and the General Medical Council11 have
commissioned research studies of the implementation
of medical revalidation. The General Medical Council
has recently commissioned Sir Keith Pearson, Chair of
the General Medical Council’s Revalidation Advisory
Board, to lead a review of revalidation.12
Methods
We conducted a survey of all Responsible Officers in
the UK between June and September 2015. We col-
lected information about how revalidation has been
implemented and what resources have been required,
how it has interacted with or influenced appraisal and
other organisational systems for managing medical
performance, what impact it is perceived to have
had on these systems and on clinical practice, and
how revalidation recommendations have been made.
We also sought the views of Responsible Officers
about the implementation of revalidation and their
suggestions for improving revalidation in the future.
A significant proportion of Responsible Officers
fulfil the role for more than one designated body,
so to avoid survey overload, we surveyed each of
these Responsible Officers only once about the desig-
nated body with the greatest number of doctors. A
total of 595 survey invitations were issued to
Responsible Officers across the UK, and 374 com-
pleted survey responses were received (response rate
63%). The response rate did not differ significantly
between the countries of the UK or the different
regions within England, or between designated
bodies who self-reported higher or lower annual
appraisal rates in their returns to NHS England, sug-
gesting the responses were broadly representative of
designated bodies generally. There was however a sig-
nificantly lower response rate (just under 50%) from
Responsible Officers responsible for designated
bodies with less than 20 doctors and from
Responsible Officers for locum agencies.
We analysed numeric and Likert scale data from
survey respondents using frequency tables and cross-
tabulations, identifying statistically significant
differences through Chi-square tests. We conducted
thematic analyses of free text comments. Themes
were identified inductively in relation to each ques-
tion and then compared across questions in order to
identify common, cross-cutting themes.
Results
The role of Responsible Officers
Responsible Officers have statutory responsibility for
implementing medical revalidation. We found that a
high proportion of Responsible Officers are in very
senior, board level roles in their designated bodies
(64% were the medical director, 6% were an associate
or deputy medical director, 8% were consultants and
17% had other roles such as chief executive, deputy
chief executive, postgraduate dean, etc.). On average,
Responsible Officers had been working in or with their
designated body for 10 years. About 15% of
Responsible Officers were responsible for multiple
designated bodies, with almost 5% being responsible
for three or more designated bodies. They reported
spendinganaverageof5.1hoursaweekon revalidation.
Figure 1 provides some illustrative comments from
Responsible Officers about their role. First, they
emphasise the workload involved for them personally
and for colleagues, and the administrative resource
commitment required from their organisations
(which was not always forthcoming). Second, they
comment on the increased authority and hierarchical
power which the Responsible Officer role has given
them. Some see this positively – as allowing them to
address concerns about quality more effectively, and
giving them some leverage for change – but others
express concern that it changes the professional, col-
legial relationship they have had with other doctors
and that the powers could be misused.
Organisational mechanisms for quality assurance
or improvement
We asked Responsible Officers a common set of ques-
tions about five mechanisms for quality assurance or
improvement which are used in the appraisal or reval-
idation process: appraisal, complaints, significant
events or serious untoward incidents, quality improve-
ment/clinical audit and continuing professional devel-
opment. We also asked about two mechanisms for
dealing with poor performance: arrangements for
doctors who give cause for concern and formal fitness
to practise referral. We were interested in how insti-
tutionalised or embedded these mechanisms were, so
we asked about the Responsible Officer’s knowledge
of each one, about whether there was a written policy
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about it, about compliance by doctors with that policy
and about whether the designated body’s board
received reports about the mechanism. We also
asked if each mechanism had changed due to revalid-
ation. The results are shown in Figure 2.
It can be seen that three of these mechanisms –
appraisal, complaints and serious untoward incidents
– are reported to be well institutionalised with high
levels of knowledge about them reported by
Responsible Officers, organisations having written
policies, high compliance reported with those policies
and information about these mechanisms being
reported to the organisation’s board. However, two
– quality improvement/clinical audit and continuing
professional development – have generally lower
levels of reported institutional embedding. It can also
be seen that Responsible Officers also report high
levels of knowledge of arrangements for managing
concerns and dealing with fitness to practise.
As the graph shows, 82% of Responsible Officers
reported that the way appraisals were done had chan-
ged due to the introduction of medical revalidation,
and 46% similarly reported changes in the arrange-
ments for dealing with doctors causing concern.
Between 25% and 40% of Responsible Officers
reported changes in the other mechanisms shown in
Figure 2. Some examples of their descriptions of these
changes are in Figure 3. Across all these systems for
quality assurance and improvement, Responsible
Officers tended to report that there was greater
engagement or participation, that systems were
more robust and more formalised, that records of
these activities were better kept, that action planning
and follow-up in these systems was better and that
there was more sharing of information across these
systems and within the organisation. Overall, the
Figure 1. The role of Responsible Officers.
Workload 
• “The revalidaon process was conceived and launched many years ago without any significant 
regard or involvement of those who would have to implement it. That is the role of 
Responsible Officer oen fell to medical directors, who already had a full metable.”  
• “It is just one of the tasks that need to be incorporated into an individual's job. It has to be 
priorised alongside all their other work. Gapped admin posts have been a constraint on the 
implementaon of revalidaon” 
•  “Only obstacles are resources; me, energy and costs.  I also do not get the impression that the 
revalidaon process was considered in sufficient detail before the launch.  Quesons are oen 
responded to by saying that there is no answer, but that it will get 'figured out'.  This uncertainty 
leads to me, funds and energy losses.  I would have liked to see that the introducon was, and 
current process is, smoother - more business-like, clearer processes and policies, perhaps with 
more legal input and support.”   
• “…has added to my usual workload but on the posive side, has given me a framework with 
which to idenfy problems and act upon them.” 
Formal authority, power and hierarchy 
• “More work! But actually makes the job easier somemes as now there is a formal process to 
tackle problems compared to before-i.e.. some teeth!”  
• “It has undoubtedly increased my workload, but it allows me a clear jusficaon for the quality 
work that must be delivered with reference to healthcare professionals” 
• “I now have a much stronger grip on the performance and conduct of doctors, and have been 
able to use the needs of appraisal and revalidaon to bring about a number of quality 
improvements that have benefied the whole organisaon.” 
• “[there is] some slightly greater engagement with doctors but I think they all now associate the 
Medical Director with being a policeman/headmaster/oppressor.” 
• “I became Responsible Officer aer revalidaon was introduced. It gives the
Medical Director a lot of (unwelcome) power.”  
Figure 2. Organisational mechanisms for quality assur-
ance or improvement, and the impact of revalidation.
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introduction of revalidation had had some wider
effects on the way that organisations deal with quality
assurance and improvement, particularly in relation
to doctors’ performance.
About 34% of Responsible Officers reported that
there had been more cases of doctors causing concern
coming to light since the introduction of revalidation,
and 26% of Responsible Officers said there were
more fitness to practise case referrals to the General
Medical Council. Almost all of the rest said there had
been no change in the rates of these cases – only 3%
said rates of doctors causing concern or fitness to
practise referral had fallen.
Decision-making on revalidation recommendations
The formal revalidation recommendation from the
Responsible Officer to the General Medical Council
can be to revalidate, to defer revalidation on grounds
of insufficient information or an ongoing local pro-
cess (such as an investigation) or to report non-
engagement on the part of the doctor. There is no
option to recommend deferring or withholding reval-
idation because of the doctor’s performance.13
We asked Responsible Officers about how they
arrived at revalidation recommendations and what rec-
ommendations they had made. They reported that
information from all the mechanisms for quality assur-
ance or improvement discussed earlier was usually used
in these decisions. We found that 88% of Responsible
Officers typically reviewed documentation as part of
their decision process; with 41% of Responsible
Officers reporting that they usually discussed cases
with a colleague and 22% reporting that cases were for-
mally reviewed by a committee (Responsible Officers
could say they used more than one of these methods,
and it was common for Responsible Officers to report
that more difficult or complex cases were discussed for-
mally or informally). TheResponsible Officer is person-
ally responsible in statute for the revalidation
recommendation but 26% of responding Responsible
Officers said they, on some occasions, confirmed a rec-
ommendationmade by someone else, who had typically
reviewed the case documentation, etc.
Figure 3. Reported changes in organisational mechanisms for quality assurance or improvement due to the introduction of
medical revalidation.
• “The appraisal process is much more robust with the introducon of revalidaon.  The quality is 
connuously checked and improvements made as a result of findings.  Our compliance rate has 
improved significantly.” 
• “Prior to my arrival, all connuing professional development was 'signed off' as appropriate
by a non-medical member of staff. As Responsible Officer, I now sign off all
connuing professional development requests, ensuring that connuing professional
development is appropriate to both the individuals' as well as the organisaons overall needs” 
• “We have a system that ensures that any complaint acvity is not only fed back to the Dr 
involved - but also to their appraisal. It is part of a corporate informaon sheet which has to be 
discussed at appraisal” 
• “As an Responsible Officer, I now ask quesons about complaints and how they were
invesgated / resolved that previously I may not have had any knowledge of.”  
• “Annual appraisal is a powerful reminder to medical staff about importance of engaging within 
Quality Improvement acvies” 
• “Learning from audits/ inspecons and process improvement iniaves typically leads to 
excellent reflecon - and very clear Correcve Acons and Plans. These acvies are given high 
weighng in 'evidence review'” 
• “There is a formal [serious untoward incidents] process to follow now, whereas prior to
revalidaon there was no one process, and the doctors involved were somemes not taken to
task in the same way as they are now.”    
• “[Doctors who give cause for concern] It is more formalised and we have a remediaon policy
with more support. We have implemented coaching for doctors for example.  We have nine trained
consultant coaches who coach other consultants as part of a local remediaon process.  This has
in my view "saved" careers as well as help doctors improve their skills and so healthcare delivery.  I     
• “Doctors who give cause for concern: It is a far more robust process now. The linkage with the
ELA has helped communicaon with the General Medical Council.”   
• “I think perhaps people are more likely to raise concerns about colleagues now than before” 
• “1. Less tolerance of doctors not fit to pracce; 2. Beer understanding of what 'good' looks like; 
3. Colleagues know that raising concerns is part of their duty as a doctor, even about colleagues” 
• “We have far more [fitness to pracce] cases coming forward and they are exceedingly complex.
 We have forged a close relaonship with our ELA who provides us with an excellent service” 
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The threshold for making a positive recommenda-
tion to revalidate seems ambiguous – 28% of
Responsible Officers reported that they had made a
positive revalidation recommendation while still
having residual concerns about a doctor.
Responsible Officers can recommend deferral either
because they have insufficient information in the
portfolio of supporting information (78% reported
they had done so about at least one doctor) or
because there is some form of ongoing local process
such as an investigation (44% had done so again
about at least one doctor). The only other option
for Responsible Officers is to make a recommenda-
tion of non-engagement which can lead to the
General Medical Council taking away the doctor’s
licence to practise and 27% reported making at
least one such recommendation.
Responsible Officers commented on the challenges
and uncertainties of making revalidation recommen-
dations (Figure 4). First, there was uncertainty about
the quality and accuracy of the supporting informa-
tion in the portfolio from the doctor, and some
Responsible Officers expressed reservations about its
completeness. Second, there was uncertainty about
how or whether to use ‘soft intelligence’ about the
doctor if they had it, especially when the portfolio
of supporting information seemed adequate but
their personal knowledge of the doctor gave them
some cause for concern. Third, there was uncertainty
about what recommendation to make in the cases of
doctors where there were concerns about their per-
formance but which had not yet triggered any formal
process. It seemed that deferral was being used in
such cases, though this is not in accordance with
the General Medical Council guidance.
Impact on clinical practice and quality of care
We asked Responsible Officers for their views on what
impact the various mechanisms for quality assurance
and improvement listed earlier (inFigure 2) hadhadon
clinical practice, and their responses are shown in
Figure 5. All mechanisms were seen as having little or
no negative impact, and while between one-quarter
and one-third of Responsible Officers reported that
these mechanisms had no impact, between two-thirds
and three-quarters reported positive impacts on clin-
ical practice.
Some Responsible Officers gave examples of such
changes, of which most (94%) were positive and few
(6%) were negative. Positive reported changes related
mostly to improved clinical standards, reflective prac-
tice, quality assurance and follow-up on instances of
poor performance or behaviour. Negative reported
changes related to these activities reducing the time
doctors had to spend on direct patient care, and them
contributing to or causing a less open, supportive or
nurturing culture in which doctors might be less will-
ing to raise or share problems.
Improving revalidation
Responsible Officers commented extensively about
how revalidation could be improved (Figure 6).
First and perhaps most commonly, they saw a need
to improve the quality of the annual appraisal process
which is central to medical revalidation, through
better training for appraisers and more quality assur-
ance. Second, some Responsible Officers believed that
there should be greater flexibility to tailor the reval-
idation model to fit particular organisational or
Figure 4. Challenges in arriving at revalidation recommendations.
• “The definion of concern is broad and ill-defined. I have concerns about several of my colleagues 
but nothing objecve and lile in wring. This is not a robust enough evidence trail for acon or 
not giving a recommendaon that is posive” 
• “Issues that were below the threshold for formal invesgaon and insufficient to warrant a 
deferral - e.g. minor behavioural issues, issues related to the age of the individual but where 
competency was not shown to be materially flawed.” 
• ‘More oen than not the concern relates to the quality of the evidence in the Doctors porolio 
rather than the Doctor per se. Some Doctors whom I have some concern about produce excellent 
porolios’.  
• “Minor behavioural concerns that were addressed at the me but subsequently have escalated 
again.  In some doctors they ck all the boxes and can evidence everything that they need to - as 
an Responsible Officer you can only really act on the evidence before you and not the "gut reacon."” 
• “There are always a few doctors where I and my team spend me discussing the evidence 
because of some concerns.   In some instances we have asked the doctor to parcipate in specific 
educaonal or improvement acvity.   We probably now are more inclined to defer if [in] doubt, 
aer an experience where we had a posive recommendaon and the CQC subsequently visited 
the pracce where the doctor worked and discovered very unsafe pracce” 
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professional contexts. For example, Responsible
Officers in small and non-NHS organisations saw
revalidation as onerous, bureaucratic and designed
for large NHS organisations. They wanted a lighter
touch approach. Third, some Responsible Officers
identified particular difficulties in completing apprai-
sal and revalidation for doctors who moved fre-
quently between organisations (such as locums) or
who had portfolio careers across a number organisa-
tions. The Responsible Officer in their designated
Figure 6. Responsible Officer’s proposals for improving medical revalidation.
• “It is appraisal that is the much more important component, and that training is needed for 
appraisers to support generaon of a high quality appraisal, and a PDP focused on idenfying 
the real development need and followed by acon to be taken to meet this in the interest of 
improved health outcome. The quality of appraisers, their training and assurance is therefore 
key. […] Revalidaon as a concept should therefore major on the quality of appraisal; having a 
high quality appraisal should generate an (almost) automac recommendaon for revalidaon, 
in the absence of concerns arising from other sources.” 
• “A two-er system would be less onerous for small organisaons where the issues are oen very 
different - and once the structures are in place it is more knowing where to get advice in order to 
ensure consistent decisions made when there are concerns, rather than needing frequent 
network meengs.”  
• “We need to ensure that doctors are supported and that the pendulum does not swing too far in 
the direcon of an authoritarian or even dystopian future with austere processes and 
disenfranchised and disillusioned workforce.” 
• “Communicaon of revalidaon and appraisal history with supporng intelligence re: 
complaints, claims, SIs and remediaon/capability between Responsible Officers needs to be
standardised.” 
• “The variety of ways that appraisal is captured can be problemac and standardisaon would be 
helpful (although difficult to agree).  Finding out who a doctor is working for across their whole 
scope of pracce is based upon self-declaraon.  If employers were made to declare which 
doctors undertook work for them and this was on GMC Connect [revalidaon informaon 
system] then it would be easier to contact all employers to get the informaon necessary to 
support revalidaon.” 
• “I personally suggest a new category of me-limited provisional or probaonary revalidaon for 
those who have on-going issues which may or may not be resolved.  Responsible Officers should
have the power to vary RV [revalidaon] dates for doctors.  This would be especially helpful for
those approaching rerement.     
• “Formal tests of competence starng with a wrien exam every 5 years.  I know exams do not 
test behaviour or the applicaon of knowledge parcularly well but if a doctor doesn't have the 
knowledge in the first place s/he certainly cannot apply it!” 
• “There is lile evidence to suggest that lack of knowledge or skills is a large problem. Generally it 
is poor behaviours and we need a much more robust method of idenfying and addressing those 
types of issue.” 
Figure 5. Impact of mechanisms for quality assurance or improvement on clinical practice.
A lot worse A lile worse No change A lile beer A lot beer 
N  % N % N  % N  % N  % 
Appraisal 0 0% 0 0% 83 23% 212 59% 65 18% 
Parcipaon in CPD 0 0% 1 0% 110 35% 145 46% 59 19% 
Responses to complaints 1 0% 2 1% 100 30% 171 51% 63 19% 
Parcipaon in quality 
improvement 0 0% 3 1% 70 21% 179 53% 86 25% 
Responses to significant 
events/SUIs 0 0% 1 0% 84 25% 173 51% 83 24% 
Acons taken in cases of 
doctors causing concern 0 0% 0 0% 102 31% 136 42% 88 27% 
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body was expected to take account of their perform-
ance across the whole of their professional practice,
but mechanisms for sharing information between
organisations or transferring it between Responsible
Officers were not seen as being well developed.
Discussion
Overall, we find that medical revalidation has so far
had some important impacts on the way that medical
performance is managed and assured – in particular
strengthening oversight within organisations (espe-
cially those which did not have robust systems in
place before) and improving liaison with and commu-
nication with the General Medical Council. Of
course, our survey is based on self-reports from
Responsible Officers and we cannot verify their
responses. While our response rate is good, there
are some measured differences between respondents
and non-respondents which could affect our results,
and unmeasured differences could also exist.
We find that revalidation has helped to integrate
often diverse sources of information within organisa-
tions and has given the Responsible Officer the
authority and scope to bring together information
on performance and to act upon it. The greatest
reported impact has been on appraisal, and many
Responsible Officer suggestions for improvement
were intended to make appraisal and revalidation
work better for doctors who are already performing
well. A sizeable minority of Responsible Officers felt
that more cases of doctors causing concern had come
to light since the implementation of revalidation, and
also that there had been more fitness to practise refer-
rals. This is consistent with systems being more
robust, but might also be due to Responsible
Officers becoming more risk averse, with lower
thresholds for raising concerns or taking action.
The introduction of medical revalidation has
brought into being the role of the Responsible
Officer at organisational level, filled by a senior
doctor, with concomitant responsibilities, powers
and opportunities. In some designated bodies this
seems to be changing relationships between the
Responsible Officer and medical colleagues, giving
the Responsible Officer greater authority over med-
ical practice. It has also created or strengthened exter-
nal relationships, between Responsible Officers (in
part through the Responsible Officer network meet-
ings they attend) and between Responsible Officers
and the General Medical Council.
However, there are concerns about the consistency of
medical revalidation within and between organisations
and about its coverage, particularly of doctors who do
not work predominately in one organisation, but who
move between organisations and have portfolio careers.
The transfer of information about medical performance
between organisations seems problematic. The revalid-
ation model seems to suit large organisations with the
capacity to put systems in place but works less well for
smaller organisations who employ only a few doctors.
The extent to which the Responsible Officer can exercise
effective oversight reduces as the ‘organisational dis-
tance’ to the doctor or ‘organisational transience’
increases. A key challenge would appear to be balancing
economies of scale in revalidation systems and adminis-
tration against the Responsible Officer having a good
knowledge of the doctors and organisations they cover
and effective means to influence policy and practice in
those organisations.
Moving from a ‘one size fits all’ single model of
revalidation to allow some legitimate and appropriate
variation in the way the policy is applied seems to
have widespread support. This might mean differ-
ences in the way revalidation works with organisa-
tions having either many or few employed doctors;
with organisations where there is a particularly close
or particularly distant relationship with employed
doctors; with doctors in different fields or specialties,
due to the clinical content and nature of their work;
and perhaps more controversially with individual
doctors according to their past and current perform-
ance track record. Many would like to see revalid-
ation made less bureaucratic and time consuming.
Conclusions
It is very difficult to answer the question of what
impact medical revalidation has had or will have on
clinical practice and the quality of medical care, and
more research on this is needed. There are some early
positive indications from this survey, and we are
exploring both the costs and benefits of medical reval-
idation further both qualitative and quantitatively in
our ongoing research programme. It seems likely that
the impact so far is mostly focused on identifying and
dealing with poor performance, and there is more to
be done to ensure that revalidation has benefits and
impact for doctors who perform well already.
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